The University of Puerto Rico, Medical Sciences Campus — Universidad de Puerto Rico, Recinto de Ciencias Médicas in Spanish— is a public health sciences-oriented university in San Juan, Puerto Rico. It is part of the University of Puerto Rico System and is located on the grounds of the Puerto Rico Medical Center.

During the past decade, University of Puerto Rico - Medical Science Campus; Internal Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Puerto Rico - Medical Science Campus; Internal Medicine" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "University of Puerto Rico - Medical Science Campus; Internal Medicine" in a lesser frequency.

Most popular intervention types in "University of Puerto Rico - Medical Science Campus; Internal Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Puerto Rico - Medical Science Campus; Internal Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Puerto Rico - Medical Science Campus; Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Puerto Rico - Medical Science Campus; Internal Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Puerto Rico - Medical Science Campus; Internal Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".